Elecsys Afp
Kit, Test,Alpha-Fetoprotein For Testicular Cancer. 510(k) K981282, from Roche Diagnostics GmbH (Pleasanton, CA). Product code LOJ, class 2.
As of Nov 20, 2026, K981282 is an FDA 510(k) held by Roche Diagnostics GmbH, substantially equivalent on May 1, 1998 after 23 days, with no recalls tied to it in FDA's recall database.
- Review time: 23 days
- Recalls: 0
- Cited as a predicate by: 2 devices
Immunoassay for the in vitro quantitative determination of alpha-fetoprotein in human serum and plasma to aid in the management of patients with non-seminomatous germ cell tumors. The electrochemiluminescence immunoassay “ECLIA” is intended for use on the Boehringer Mannheim Elecsys 1010 and 2010 immunoassay analyzers.
- Elecsys AfpK973351 · Boehringer Mannheim Corp. · Nov 21, 1997
- Elecsys AFPK220176 · Roche Diagnostics · Sep 15, 2022
- Roche Diagnostics Elecsys Afp Calset IiK043095 · Roche Diagnostics Corp. · Nov 23, 2004
- Elecsys AFPK220176 · Roche Diagnostics · Sep 15, 2022
- Vitros AfpK213626 · Ortho Clinical Diagnostics · Jun 15, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Apr 8, 1998
- Review panel
- Immunology
- Regulation
- 21 CFR 866.6010
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files